Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IGF1R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANP32E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDKN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM126B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AURKA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C2orf69 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPT-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MRPL19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMHB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAMTS19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCT6A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OXCT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFXN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP70 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF573 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDHB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR7E14P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on